Chemo-Immunotherapy of Murine Cancer Using Alpha Tocopheryl Succinate and Non-Matured Dendritic Cells
The search for anticancer drugs that are tumor specific and cause minimal side effects and the development of effective cancer vaccines are focal points of cancer therapy today. Dendritic cells (DC) are considered potential candidates for cancer immunotherapy due to their ability to process and pres...
Main Author: | Ramanathapuram, Lalitha |
---|---|
Other Authors: | Akporiaye, Emmanuel T. |
Language: | EN |
Published: |
The University of Arizona.
2006
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/194412 |
Similar Items
-
Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and α-tocopheryl succinate enhance anti-tumor effect in vivo
by: Lei X, et al.
Published: (2017-08-01) -
Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by D-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate
by: Qiao H, et al.
Published: (2017-02-01) -
Combination Delivery of Alpha-Tocopheryl Succinate and Curcumin Using a GSH-Sensitive Micelle (PAH-SS-PLGA) to Treat Pancreatic Cancer
by: Tilahun Ayane Debele, et al.
Published: (2020-08-01) -
Tocopheryl Succinate-Induced Structural Changes in DPPC Liposomes: DSC and ANS Fluorescence Studies
by: Grażyna Neunert, et al.
Published: (2020-06-01) -
Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system
by: Zhao X, et al.
Published: (2018-12-01)